All episodes

Setting a vision: how an impact-driven pharmaceutical company prioritizes sustainability (Part 1)

Setting a vision: how an impact-driven pharmaceutical company prioritizes sustainability (Part 1)

15m 35s

In this episode of “10 Billion Reasons”, Krizia Karry sits down with Bailey Risteen, BASF Pharma Solutions Global Sustainability Manager, and Tony Sorenson, Founder and Impact Ambassador of 75Pharma, to discuss what it means to be impact-driven pharmaceutical company, how environmental sustainability fits into the corporate strategy, and what the value chain can do to support that strategy .

Influence of excipients on dermal drug delivery

Influence of excipients on dermal drug delivery

12m 20s

In this episode of “10 Billion Reasons”, our host, Nigel Langley and guests, Gloria Ho and Norman Richardson discuss the role of excipients in dermal drug delivery.

The Landscape of Amorphous Solid Dispersions

The Landscape of Amorphous Solid Dispersions

18m 2s

In this episode of “10 Billion Reasons”, BASF Global Technical Marketing Manager for Solubilization, Dr. Lindsay Johnson, and BASF Senior Manager of South Asia Technical Services and Application Lab, Dr. Rajkiran Narkhede, discuss the landscape of amorphous solid dispersions with host, Nigel Langley.

Continuous manufacturing implementation in pharma: advantages and challenges

Continuous manufacturing implementation in pharma: advantages and challenges

15m 59s

In this episode of “10 Billion Reasons”, Joao Assis and Krizia Karry brainstormed about the advantage of implementing continuous manufacturing in the pharmaceutical industry, covering the economic aspects, product attributes, quality assurance and process control.

Fishing for answers in a sea of complexity: sustainable fish oil sourcing

Fishing for answers in a sea of complexity: sustainable fish oil sourcing

14m 45s

In this episode of “10 Billion Reasons”, Bailey Risteen, BASF Pharma Solutions Global Sustainability Manager, sits down with Manfred Haag and Douglas Pereira Souza on the procurement team to discuss challenges and best practices in sourcing fish oil and how BASF is taking action.

Streamline the tableting process with a co-processed excipient

Streamline the tableting process with a co-processed excipient

17m 27s

In this episode of “10 Billion Reasons”, our host, Nigel Langley and guests, Joao Assis and Ashish Joshi discuss the benefits of using co-processed excipients and the significant advantages they can provide to the pharmaceutical industry.

What is new: Trends in Biopharma

What is new: Trends in Biopharma

17m 31s

In this episode of “10 billion Reasons”, Phil Butler Technical Manager and Nadya Morales-Cummings, Global Tech Marketing Manager for Biopharma Ingredients, tackle new and emerging topics in the biopharma market.

Is there a

Is there a "Green Pill"? Sustainability in the Pharmaceutical Industry

14m 40s

In this episode of “10 Billion Reasons”, Bailey Risteen, BASF Pharma Solutions Global Sustainability Manager, explains some of the challenges and opportunities in creating a more sustainable pharmaceutical industry and the progress already being made.